Search research articles
Contact Us
Filters
Showing results (41-50 of 1,526) with videos related to
Page
of 153
Sort By:
Annals of the Royal Australasian College of Dental Surgeons
|
November 4, 2011
Molar incisor hypomineralization: clinical management in children
Peter D Wong
Journal of the American College of Cardiology
|
November 16, 2019
Identifying the Very-High-Risk Atherosclerotic Cardiovascular Disease Patient: Does It Really Matter?
Nathan D Wong
The American Journal of Cardiology
|
August 14, 2017
Residual Risk After Treatment of Patients With Atherosclerotic Cardiovascular Disease With Proprotein Convertase Subtilisin-Kexin Type 9 Monoclonal Antibody Therapy (from the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Trial)
Nathan D Wong
Metabolic Syndrome and Related Disorders
|
March 29, 2008
The metabolic syndrome and preventive cardiology: working together to reduce cardiometabolic risks
Nathan D Wong
American Journal of Preventive Cardiology
|
July 30, 2021
Cardiovascular risk assessment: The foundation of preventive cardiology
Nathan D Wong
Canadian Journal of Physiology and Pharmacology
|
June 30, 2022
Cardiodiabetology: newer pharmacologic strategies for reducing cardiovascular disease risks
Nathan D Wong
JACC. Cardiovascular Imaging
|
June 3, 2023
Is a Picture Worth a Thousand Words?
Nathan D Wong
Preventive Cardiology
|
February 6, 2002
Reflections on cardiovascular risk stratification and prevention
N D Wong
Hawaii Medical Journal
|
October 1, 1991
The Hawaii Medical Fellowship Mission to China
B D Wong
Hawaii Medical Journal
|
December 29, 1998
A laparoscopic update
B D Wong
Page
of 153
Search research articles
Search
Showing results (41-50 of 1,526) with videos related to
Sort By:
Page
of 153
Annals of the Royal Australasian College of Dental Surgeons
|
November 4, 2011
Molar incisor hypomineralization: clinical management in children
Peter D Wong
Journal of the American College of Cardiology
|
November 16, 2019
Identifying the Very-High-Risk Atherosclerotic Cardiovascular Disease Patient: Does It Really Matter?
Nathan D Wong
The American Journal of Cardiology
|
August 14, 2017
Residual Risk After Treatment of Patients With Atherosclerotic Cardiovascular Disease With Proprotein Convertase Subtilisin-Kexin Type 9 Monoclonal Antibody Therapy (from the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Trial)
Nathan D Wong
Metabolic Syndrome and Related Disorders
|
March 29, 2008
The metabolic syndrome and preventive cardiology: working together to reduce cardiometabolic risks
Nathan D Wong
American Journal of Preventive Cardiology
|
July 30, 2021
Cardiovascular risk assessment: The foundation of preventive cardiology
Nathan D Wong
Canadian Journal of Physiology and Pharmacology
|
June 30, 2022
Cardiodiabetology: newer pharmacologic strategies for reducing cardiovascular disease risks
Nathan D Wong
JACC. Cardiovascular Imaging
|
June 3, 2023
Is a Picture Worth a Thousand Words?
Nathan D Wong
Preventive Cardiology
|
February 6, 2002
Reflections on cardiovascular risk stratification and prevention
N D Wong
Hawaii Medical Journal
|
October 1, 1991
The Hawaii Medical Fellowship Mission to China
B D Wong
Hawaii Medical Journal
|
December 29, 1998
A laparoscopic update
B D Wong
Page
of 153